Results 241 to 250 of about 120,857 (300)
Some of the next articles are maybe not open access.

Outcome of Chagas cardiomyopathy in comparison to ischemic cardiomyopathy

International Journal of Cardiology, 2013
Chagas cardiomyopathy and ischemic heart disease (IHD) are frequent causes of chronic systolic heart failure (CHF) in areas where the former is endemic. Nonetheless, a specific comparison of outcome and role of etiology of CHF failure has not been performed in patients with both conditions.Two-hundred twenty two patients with Chagas cardiomyopathy and ...
Reinaldo B Bestetti   +2 more
exaly   +3 more sources

Ischemic cardiomyopathy

Progress in Cardiovascular Diseases, 1984
The term "ischemic cardiomyopathy" was used initially to describe a clinical syndrome that was indistinguishable from primary congestive cardiomyopathy but due to severe, diffuse coronary artery disease. The term has been expanded to include the larger category of myocardial disease secondary to coronary artery disease.
G A, Pantely, J D, Bristow
openaire   +2 more sources

Dystrophin: From non-ischemic cardiomyopathy to ischemic cardiomyopathy

Medical Hypotheses, 2008
Dystrophin and its associated proteins form a scaffold underneath the cardiomyocyte membrane and connect the intracellular cytoskeleton to the extracellular matrix. Dystrophin localizes at the X chromosome, whose mutations might result in Duchenne muscular dystrophy, Becker muscular dystrophy and X-linked dilated cardiomyopathy.
Qiang Sun, Zheng   +5 more
openaire   +2 more sources

Q waves in ischemic cardiomyopathy

The International Journal of Cardiovascular Imaging, 2021
Q waves may be observed in the absence of non-viable tissue. However, their scintigraphic translation in patients with ischemic cardiomyopathy (ICM) has not been properly assessed. This study sought to establish the determinants of Q waves in the absence of non-viable tissue and the diagnostic accuracy in this population.
Eduard Ródenas-Alesina   +7 more
openaire   +2 more sources

Relief of Ischemia in Ischemic Cardiomyopathy

Current Cardiology Reports, 2021
Ischemic heart disease is among the most common causes of morbidity and mortality worldwide. In its stable manifestation, obstructing coronary artery stenoses prevent myocardial blood flow from matching metabolic needs of the heart under exercise conditions, which manifests clinically as dyspnea or chest pain.
Francesco, Moroni   +2 more
openaire   +2 more sources

Lipomatous metaplasia in ischemic cardiomyopathy

Journal of Cardiovascular Medicine, 2009
Lipomatous metaplasia is characterized by substitution of muscle fibers with adipose tissue in the context of a myocardial scar. Cardiac magnetic resonance is an accurate cardiac imaging technique with high tissue spatial resolution that can easily characterize scar tissue, adipose tissue and lipomatous metaplasia.
DI BELLA, Gianluca   +7 more
openaire   +2 more sources

Therapy of Ischemic Cardiomyopathy with Pentoxifylline

Angiology, 1990
Abnormal blood rheology is a known characteristic of coronary artery disease. The authors evaluated the effects of pentoxifylline on the exercise capacity ejection fraction and symptoms of 9 patients with ischemic cardiomyopathy. All patients had signs and symptoms of left ventricular dysfunction.
J C, Barnett, R C, Touchon
openaire   +2 more sources

Surgical remodeling in ischemic cardiomyopathy

Current Treatment Options in Cardiovascular Medicine, 2003
Ischemic cardiomyopathy has a very poor prognosis, despite significant advances in pharmacologic therapy in the past decade. Orthotopic heart transplantation is an option for only a small minority of patients. Due to donor shortage and a finite outcome after transplant, nontransplant surgical intervention should be intensively investigated.
James O., O'Neill, Randall C., Starling
openaire   +2 more sources

Ventricular reconstruction for ischemic cardiomyopathy

The Annals of Thoracic Surgery, 2003
Left ventricular surgical reconstruction has been advocated for patients with coronary artery disease, prior myocardial infarction, and poor left ventricular function. The objective of the approach is to resect or exclude all akinetic or dyskinetic nonfunctioning portions of the ventricular cavity and to restore the left ventricle size and shape toward
Lynda L, Mickleborough   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy